News

Biora Therapeutics: Pioneering New Avenues in Drug Delivery

Biora Therapeutics: Pioneering New Avenues in Drug Delivery

Biora Therapeutics Unveils Groundbreaking Presentation

Biora Therapeutics, Inc. (NASDAQ: BIOR) is excited to announce that its leadership team will be taking part in the upcoming 19th Annual Peptide Therapeutics Symposium. This event is a significant opportunity for the biotech community, bringing together leading experts in peptide research from various sectors dedicated to enhancing drug discovery and therapeutic development.

Innovative Presentation Highlights

A highlight of the symposium is a presentation titled "Empowering Peptide Self-Administration with Needle Free Smart Capsules." The event will take place virtually and in person, allowing for a wide reach of attendees interested in peptide-based innovations. This presentation is set for October 22, 2024, from 2:30 PM to 3:00 PM PT, offering a brief window into the transformative work being undertaken by Biora.

Keynote Presenter

The presentation will be delivered by Sharat Singh, PhD, Head of Research at Biora Therapeutics. Dr. Singh's expertise and insights into peptide therapeutics promise to enlighten attendees on the latest advancements and applications within this critical field.

Symposium Overview

The Peptide Therapeutics Symposium stands as a beacon for researchers and developers in the biopharmaceutical industry. Attendees can expect discussions surrounding the latest core technologies that pertain to peptide drug discovery and the enhancement of therapeutic candidates. With the event gathering top minds in the industry, the exchange of innovative ideas is anticipated to flourish.

About Biora Therapeutics

Biora Therapeutics is at the forefront of clinical-stage biotechnology, focusing on developing innovative, smart pill-based therapeutic platforms. Chief among these efforts is the NaviCap™ platform, designed specifically for the colon-targeted treatment of inflammatory bowel disease (IBD). This innovative approach aims to optimize patient outcomes through localized treatment. Additionally, the company is advancing its BioJet™ platform, which facilitates the oral delivery of larger molecules that traditionally required injection, thereby providing a needle-free alternative for managing chronic conditions.

Explore More

If you want to learn more about Biora Therapeutics and its pioneering projects, you can visit their official website or follow them on professional networking platforms to stay updated on their continuous advancements in healthcare.

Frequently Asked Questions

What is Biora Therapeutics known for?

Biora Therapeutics is a clinical-stage biotech company renowned for developing innovative smart pill-based therapeutics platforms aimed at improving patient care.

What will Biora present at the symposium?

Biora will present on the topic "Empowering Peptide Self-Administration with Needle Free Smart Capsules," highlighting advancements in peptide drug delivery.

Who is the presenter for Biora at the event?

The presentation will be delivered by Sharat Singh, PhD, who is the Head of Research at Biora Therapeutics.

When is the Peptide Therapeutics Symposium?

The symposium will take place on October 22-23, 2024, with Biora's presentation scheduled for October 22.

How does Biora's technology benefit patients?

Biora's technology enhances therapeutic delivery through smart pills, targeting treatment areas more effectively and reducing the need for injections, thereby improving patient compliance and outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Doughy Reinvents Cookie Dough with Bold New Identity

Updated Category News Views 346

A Gourmet Transformation: Doughy's New Identity Cookie dough isn't just for sneaking off a spoon anymore, or at least that's what Doughy aims to redefine with its innovative new identity. Launched from Kelly Ramey's brainchild in her Santa Monica kitchen, Doughy's journey from a homemade recipe to a retail sensation is nothing short of remarkable. Love it or hate it, this...

Continue Reading
Customized Anti-Aging Plans Revealed: Botox to Microneedling

Updated Category News Views 50

Intricacies of Aging: Beyond One-Size-Fits-All So you've hit a point in life where those wrinkles and sagging skin aren't just brushing off with a night's sleep. Enter Dr. Sherif Salama with his treasure trove of options fitting for the fussy nature of skin. The Aging Conundrum: Multifaceted Challenges Aging isn't a one-trick pony. Wrinkles crop up, volume disappears,...

Continue Reading
Atrium's Heart Therapies: ATR 1072's Promising Data

Updated Category News Views 103

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Continue Reading
Celebree's Gratitude Push: Kindness Turns into Action

Updated Category News Views 132

Expressing Gratitude: More than Just Words Gratitude: it's one of those feel-good concepts that everyone nods to, but let's face it—most folks don't really go beyond the occasional 'thanks.' That's where the Generation Gratitude Project by Celebree School steps in. The idea's not just about saying thanks, but about making it a real, action-oriented habit. This campaign,...

Continue Reading
WaterField's Starlink Case: Compact Yet Professional

Updated Category News Views 25

Packing a Punch From Every Angle Listen, I've seen about every bag known to tech warriors, but WaterField's new Starlink Mini Go Case? It's turning some heads in the gizmo storage game. The folks at WaterField Designs, cooking out of San Francisco since '98, have whipped up something here that takes those clunky, military-style cases and swaps them for sleek, professional...

Continue Reading
Stellantis Harnesses AI for Customer Connection Boost

Updated Category News Views 135

Trading Mayhem: Pre-Market Vibes Ever put your ear to the ground on the NYSE floor and felt that buzz of untamed optimism clashing with skepticism? Today it's all about connections, from the data-driven to the familial. Imagine Stellantis (NYSE: STLA) is making a play, aligning with Amperity in an ambitious attempt to make customer interactions feel more personal. Now,...

Continue Reading
Discover Myrtle Beach's Festive Charm This Season

Updated Category News Views 52

Uniquely Coastal Celebrations in Myrtle Beach Forget the snow, friends. Picture this: you’re swapping out cozy firesides for ocean breezes this holiday season. Down in Myrtle Beach, the holidays have a bit of a coastal twist. From the vibrant Boardwalk along the oceanfront to the historic charm of riverside Conway, this area is lighting up its 14 different communities...

Continue Reading
Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026

Updated Category News Views 49

Neurocrine's Triple-Digit Surge Neurocrine Biosciences is on a tear, pushing its revenue up to a jaw-dropping $1.1 billion in Q3 2026—a hefty 41% leap from the previous year. Frankly, you can't ignore those numbers. INGREZZA, which is practically becoming a cash cow, did $801 million alone, rising 17% year over year. This rides the wave of prescription surges and solid...

Continue Reading
Home Ownership in MS: Beyond Just a Mortgage

Updated Category News Views 61

Navigating the Real Costs of Homeownership in Mississippi The sunny dreams of first-time homebuyers in Mississippi often get clouded by the storm that is unforeseen expenses. You sign on the dotted line and suddenly discover that a cozy home comes with more financial baggage than just a mortgage. Steve Houck, the go-to real estate guru in Ridgeland, MS, delivers a wise...

Continue Reading
CodeBoxx CrewKit Forge: Decentralizing AI Development

Updated Category News Views 71

Unboxing the Machine: CodeBoxx's Ambitious Move When you're talking about shakin' up the tech world, look no further than CodeBoxx and their CrewKit Forge. Unveiled at the Titan 100 Tampa Bay gala, this AI software factory is a beast—a one-meter cube ready to replace a battalion of developers. Imagine not the sterile data centers but this thing chilling in your office,...

Continue Reading

Top 5 Most Recently Viewed Articles

Scientific Games Extends Key Partnership with Ohio Lottery

Updated Category News Views 145

Scientific Games Partners with Ohio Lottery for Continued Success Scientific Games is excited to announce its continued engagement with the Ohio Lottery, where it will serve as the primary provider of Scratch-Off games for the next ten years. This collaboration between the two organizations aims to foster substantial profits that will directly benefit education in the...

Continue Reading
Investing Wisely: Top Dividend Stocks to Consider Today

Updated Category News Views 140

Timing Your Investment Decisions For investors, selecting the right stocks to buy is crucial, but timing those purchases is just as important. Sometimes, being patient pays off, while at other times, quick action is essential. Currently, several stocks stand out as excellent opportunities for income investors to consider acquiring promptly. 1. National Storage Affiliates...

Continue Reading
Investors Urged to Join Class Action Against Lineage, Inc.

Updated Category News Views 99

Class Action Lawsuit Filed Against Lineage, Inc. Investors in Lineage, Inc. are facing a significant opportunity as Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit against the company. The lawsuit stems from allegations that the company's IPO in July 2024 may have misled investors regarding its financial health and future revenue streams. Financial...

Continue Reading
Earnings Insights: Midland States Bancorp Prepares for Reveal

Updated Category News Views 89

Midland States Bancorp Earnings Preview Midland States Bancorp (NASDAQ: MSBI) is preparing to release its quarterly earnings. Investors are eager to learn how the bank has been faring amidst changing economic conditions and what the future looks like for the company. With a wealth of anticipation surrounding the report, let’s delve into what to expect. Anticipated...

Continue Reading
Quanex Building Products Raises Dividend for Shareholders

Updated Category News Views 179

Quanex Building Products Announces Quarterly Dividend HOUSTON — Quanex Building Products Corporation (NX) is pleased to announce that its Board of Directors declared a quarterly cash dividend of $0.08 per share on its common stock. This dividend is scheduled to be paid to shareholders of record on a specified date, indicating the company's commitment to rewarding its...

Continue Reading